Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04478123
What this trial is testing

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Who this might be right for
Multiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 62
Not applicableLooking for participantsNCT05451979
What this trial is testing

HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)

Who this might be right for
Pediatric ALLTransplant; Failure, Heart
University of Alberta 10
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Post-approval studies (Phase 4)Active Not RecruitingNCT06918080
What this trial is testing

Hepatoprotective Measures for Children at High Risk of NAFLD

Who this might be right for
Non Alcoholic Fatty Liver Diseases (NAFLD)Obesity and OverweightAcute Lymphoblastic Leukemia
Ain Shams University 200
Testing effectiveness (Phase 2)Looking for participantsNCT06246162
What this trial is testing

Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma

Who this might be right for
Multiple Myeloma
Affiliated Hospital of Nantong University 30
Early research (Phase 1)Looking for participantsNCT05292664
What this trial is testing

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Who this might be right for
Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more
Andrew E. Place, MD 30
Testing effectiveness (Phase 2)UnknownNCT05272293
What this trial is testing

Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML

Who this might be right for
Acute Myeloid Leukemia
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology 15
Not applicableStudy completedNCT02007863
What this trial is testing

Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia

Who this might be right for
LeukemiaMyelodysplasiaAcute Lymphocytic Leukemia+1 more
University of Miami 2
Early research (Phase 1)Study completedNCT02649764
What this trial is testing

Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic LeukemiaRecurrent Acute Myeloid LeukemiaRecurrent High Risk Myelodysplastic Syndrome+2 more
M.D. Anderson Cancer Center 15
Early research (Phase 1)Active Not RecruitingNCT03613532
What this trial is testing

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+2 more
Jacqueline Garcia, MD 102
Large-scale testing (Phase 3)Active Not RecruitingNCT04270409
What this trial is testing

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Sanofi 337
Testing effectiveness (Phase 2)Ended earlyNCT05447663
What this trial is testing

Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Stem Cell Transplantation
Novartis Pharmaceuticals 8
Testing effectiveness (Phase 2)Study completedNCT00276809
What this trial is testing

Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 30
Testing effectiveness (Phase 2)Ended earlyNCT01139164
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

Who this might be right for
Hematological Malignancies
Medical University of South Carolina 78
Testing effectiveness (Phase 2)Looking for participantsNCT05270200
What this trial is testing

Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Who this might be right for
Leukemia, Myeloid, Acute
Zhujiang Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT01949129
What this trial is testing

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung 1,800
Testing effectiveness (Phase 2)Study completedNCT01227356
What this trial is testing

A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

Who this might be right for
Health Care QualityHealth Care Evaluation
Uppsala University 112
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789522
What this trial is testing

Safety and Efficacy of Elranatamab Plus Isatuximab, Bortezomib, and Lenalidomide in Ultra-High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China 15
Not applicableStudy completedNCT04637464
What this trial is testing

Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer

Who this might be right for
Neutropenia, FebrilePediatric Cancer
Kjeld Schmiegelow 93
Testing effectiveness (Phase 2)Ended earlyNCT00480987
What this trial is testing

Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaLeukemia
M.D. Anderson Cancer Center 27
Next Page